Titre:
  • Treatment of acute hepatitis C with interferon alpha-2b: early initiation of treatment is the most effective predictive factor of sustained viral response.
Auteur:Delwaide, Jean; Bourgeois, Nadine; Gérard, C.; De Maeght, S; Mokaddem, F; Wain, E; Bastens, Boris; Fevery, J; Géhénot, M; Le Moine, Olivier; Martinet, J P; Robaeys, Geert; Servais, Bruno; Van Gossum, Marc; Van Vlierberghe, Hans; Belgian Association for the Study of the Liver (BASL),
Informations sur la publication:Alimentary pharmacology & therapeutics, 20, 1, page (15-22)
Statut de publication:Publié, 2004-07
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Acute Disease
Adolescent
Adult
Antiviral Agents -- therapeutic use
Female
Hepatitis C -- drug therapy
Humans
Interferon-alpha -- therapeutic use
Male
Middle Aged
Prospective Studies
Recombinant Proteins
Remission, Spontaneous
Risk Factors
Treatment Outcome
Viral Load
Note générale:Clinical Trial
Controlled Clinical Trial
Journal Article
Multicenter Study
FLWIN
Langue:Anglais
Identificateurs:urn:issn:0269-2813
info:doi/10.1111/j.1365-2036.2004.02023.x
info:pii/APT2023
info:scp/3142723140
info:pmid/15225166